Log in

NASDAQ:RCMR1 RCM Stock Price, Forecast & News

$8.06
-0.35 (-4.16 %)
(As of 04/5/2020 10:43 AM ET)
Add
Compare
Today's Range
$7.88
Now: $8.06
$8.46
50-Day Range
$7.57
MA: $11.12
$13.91
52-Week Range
$7.12
Now: $8.06
$13.99
Volume1.20 million shs
Average Volume1.63 million shs
Market Capitalization$922.55 million
P/E RatioN/A
Dividend YieldN/A
Beta0.46
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides modular services comprising physician advisory services, which assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; and revenue capture services, including charge capture, charge description master maintenance, and pricing services. It serves healthcare providers, including health systems and hospitals, physicians groups, and municipal and private emergency medical service providers, as well as intermountain homecare, hospice and palliative care, and durable medical equipment and infusion therapy business. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is headquartered in Chicago, Illinois.
Read More
R1 RCM logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 5.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.48 out of 5 stars


Industry, Sector and Symbol

Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Current SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.19 billion
Cash Flow$0.59 per share
Book Value$0.16 per share

Profitability

Net Income$12 million

Miscellaneous

Employees22,500
Market Cap$922.55 million
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.


R1 RCM (NASDAQ:RCM) Frequently Asked Questions

How has R1 RCM's stock been impacted by COVID-19 (Coronavirus)?

R1 RCM's stock was trading at $10.16 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RCM stock has decreased by 20.7% and is now trading at $8.06. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of R1 RCM?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for R1 RCM.

When is R1 RCM's next earnings date?

R1 RCM is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for R1 RCM.

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) announced its quarterly earnings data on Thursday, February, 20th. The healthcare provider reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.04 by $0.03. The healthcare provider had revenue of $314 million for the quarter, compared to the consensus estimate of $318.36 million. R1 RCM had a return on equity of 116.79% and a net margin of 1.01%. R1 RCM's quarterly revenue was up 19.4% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.10) earnings per share. View R1 RCM's earnings history.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.3-1.4 billion, compared to the consensus revenue estimate of $1.36 billion.

What price target have analysts set for RCM?

4 equities research analysts have issued twelve-month price targets for R1 RCM's shares. Their forecasts range from $14.00 to $17.00. On average, they expect R1 RCM's share price to reach $15.25 in the next twelve months. This suggests a possible upside of 89.2% from the stock's current price. View analysts' price targets for R1 RCM.

Has R1 RCM been receiving favorable news coverage?

Press coverage about RCM stock has trended very negative on Sunday, InfoTrie reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. R1 RCM earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the healthcare provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutR1 RCM.

Are investors shorting R1 RCM?

R1 RCM saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 7,444,000 shares, an increase of 10.1% from the February 27th total of 6,760,000 shares. Based on an average daily trading volume, of 999,400 shares, the short-interest ratio is currently 7.4 days. Approximately 7.5% of the shares of the stock are short sold. View R1 RCM's Current Options Chain.

Who are some of R1 RCM's key competitors?

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include Alibaba Group (BABA), NVIDIA (NVDA), Baozun (BZUN), Marvell Technology Group (MRVL), JD.Com (JD), Model N (MODN), Perficient (PRFT), BioDelivery Sciences International (BDSI), Baidu (BIDU) and NMI (NMIH).

Who are R1 RCM's key executives?

R1 RCM's management team includes the following people:
  • Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
  • Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
  • Mr. Richard B. Evans Jr., Sr. VP, Interim CFO, Corp. Controller & Chief Accounting Officer (Age 51)
  • Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman, Exec. VP of Compliance & Risk

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How do I buy shares of R1 RCM?

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $8.06.

How big of a company is R1 RCM?

R1 RCM has a market capitalization of $922.55 million and generates $1.19 billion in revenue each year. The healthcare provider earns $12 million in net income (profit) each year or ($0.08) on an earnings per share basis. R1 RCM employs 22,500 workers across the globe. View additional information about R1 RCM.

What is R1 RCM's official website?

The official website for R1 RCM is http://www.r1rcm.com/.

How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The healthcare provider can be reached via phone at 312-324-7820 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel